By admin 
A collaborative research effort led by scientists at Cincinnati Children’s and the University of Alabama at Birmingham (UAB) has unveiled compelling evidence suggesting that a specific wavelength of light, abundant in natural sunlight but largely absent from modern indoor environments, could be key to preventing myopia development. These pivotal findings were published online on August 18, 2026, in the esteemed journal Cell Reports Medicine, marking a significant advancement in understanding and potentially combating the myopia epidemic.
The study meticulously investigated the role of indigo light, a short wavelength within the visible spectrum, characterized by its presence in natural sunlight and its scarcity in standard white LED lighting, which dominates contemporary indoor illumination. Through a series of rigorously designed experiments utilizing tree shrews—a species whose visual system shares critical anatomical and optical similarities with that of humans—researchers made a remarkable discovery: consistent exposure to indigo light completely prevented the development of experimentally induced nearsightedness.
"The model of myopia we use in the tree shrew is fairly extreme," explains corresponding author Richard Lang, PhD, director of research in the Division of Ophthalmology at Cincinnati Children’s. "So, if indigo light can suppress myopia in these tests, then it should also be quite effective in humans." This statement reflects the profound optimism and the potential translational power of their findings, suggesting a robust protective mechanism that could be highly relevant for human populations.
Understanding the Myopia Mechanism and Its Global Impact
Myopia manifests when the eye undergoes an abnormal elongation along its front-to-back (axial) axis. This structural change causes incoming light rays to focus prematurely, in front of the retina, rather than precisely upon it. The result is blurred vision for distant objects, while near objects may remain clear. This condition typically emerges during childhood, often between ages 6 and 14, and frequently progresses through adolescence, with the degree of nearsightedness worsening over time. While glasses or contact lenses can effectively correct the blurry vision, they do not address the underlying anatomical changes or halt the progression of the condition.
Beyond the daily inconvenience of corrective lenses, severe myopia carries substantial long-term health risks. Individuals with high myopia are at a significantly increased risk of developing serious, potentially blinding eye conditions later in life, including retinal detachment, glaucoma, and myopic macular degeneration. These complications can lead to irreversible vision loss and place a considerable burden on healthcare systems. The economic cost of myopia, encompassing corrective lenses, medical treatments for complications, and lost productivity, is staggering, estimated to be hundreds of billions of dollars annually worldwide. The societal implications extend to education, career choices, and overall quality of life for affected individuals.
The Precision of the Tree Shrew Model
The choice of tree shrews for these critical experiments was not arbitrary; it was a deliberate scientific decision based on their unique ophthalmic characteristics. Tree shrews possess eyes with anatomical and optical properties that closely mirror those of human eyes, making them an ideal animal model for studying myopia development and progression. This similarity ensures that findings from tree shrew studies are highly relevant and translatable to human physiology.
First author Rafael Grytz, PhD, a distinguished visual sciences expert with the University of Alabama at Birmingham (UAB), employed a sophisticated experimental setup. He utilized miniature spectacles specifically designed for tree shrews, which induce a strong myopic signal in one eye. This technique allows for a direct comparison with the untreated eye of the same animal, providing a robust internal control and enhancing the reliability of the results. "Even though tree shrews look like squirrels, they are a near-primate, with an eye very similar to that of humans, and so are a good model to study the cause of myopia in the human population," Grytz explains, emphasizing the biological kinship that makes these animals such valuable research subjects.
To precisely track the ocular changes, the researchers exposed the tree shrews to various wavelengths of light. Throughout the experiments, their eyes were meticulously monitored using advanced ophthalmic instruments. A biometer was employed to measure the eye’s shape and axial length—the key indicator of myopic progression—while an autorefractor continuously tracked changes in refractive error over time. This rigorous methodology ensured accurate and reproducible data collection, forming the bedrock of their conclusions.
The Scientific Journey: From Violet to Indigo
The path to identifying indigo light as a protective agent was built upon earlier scientific investigations. Previous experiments conducted in mice had indicated that violet light, specifically wavelengths near 380 nanometers, could effectively reduce myopia. These studies also pinpointed opsin 5 (OPN5), a novel light-sensing receptor, as an essential component for mediating this protective effect. OPN5 is distinct from the classical photoreceptors (rods and cones) responsible for image formation; it belongs to a class of non-visual opsins involved in various biological processes, including circadian rhythms and, as now discovered, potentially refractive eye development.
However, a crucial hurdle emerged when attempting to replicate these findings in tree shrews. The human eye lens, much like that of tree shrews, naturally blocks a significant portion of light at wavelengths below approximately 400 nanometers, effectively filtering out most of the ultraviolet and short-violet spectrum. This physiological characteristic meant that the violet light effective in mice could not reach the retina in humans or tree shrews to activate OPN5.
"Human lenses, and now we know tree shrew lenses, don’t transmit a lot of light in the ultra-violet spectrum," Lang elaborates. "They basically cut off most wavelengths below 400 nanometers. This finding pushed us to explore slightly longer wavelengths that could still stimulate OPN5. Ultimately, we found that indigo light from 419 to 446 nanometers was the most effective at preventing myopia." This adaptive shift in research strategy was critical. It led the team to focus on indigo light, a wavelength capable of penetrating the eye’s lens while still effectively activating the specific biological pathway involving OPN5, thereby preventing axial elongation and myopia development.
The Deficit in Modern Indoor Lighting
These findings lend substantial weight to an increasingly accepted hypothesis: modern indoor environments, characterized by their prevalent artificial lighting, may expose developing eyes to a vastly different light spectrum than what humans experienced throughout the majority of their evolutionary history. For millennia, human eyes developed under the broad, full-spectrum light of the sun.
Standard white LED lighting, ubiquitous in homes, schools, and workplaces today, typically exhibits a peak emission around 450 nanometers (blue light) and provides ample longer-wavelength light necessary for normal vision and color perception. However, a critical deficiency lies in its relatively sparse emission of indigo light. This specific wavelength, now identified as crucial, appears to activate non-visual opsins like OPN5, which are involved in biological processes that extend far beyond simply forming images, including the regulation of eye growth.
"We evolved outside in the full-spectrum light provided by our sun," Lang asserts. "When we live inside, we don’t get all the wavelengths the eye needs for normal refractive development, and so we get myopia. That’s the basic message of this paper." This perspective highlights a fundamental disconnect between our evolved biology and our contemporary living environments, offering a compelling explanation for the rapid increase in myopia prevalence.
Addressing Myopia: Beyond Correction to Prevention
Historically, strategies for managing myopia have largely focused on correction and, more recently, on slowing progression. Traditional methods include prescription glasses and contact lenses, which merely compensate for the eye’s refractive error without addressing the underlying cause or preventing future complications. More advanced interventions include atropine eye drops, which can slow axial elongation in children, and specialized multifocal contact lenses or orthokeratology lenses, designed to create peripheral defocus to inhibit eye growth. While effective to varying degrees, these methods require active compliance and medical oversight.
One well-established strategy for reducing myopia risk is for children to spend more time outdoors. Natural outdoor environments offer several benefits: eyes are exposed to a brighter, more varied light spectrum, and children naturally engage in dynamic viewing, frequently switching focus between nearby and distant objects, which helps regulate eye growth. However, the pervasive societal shift towards indoor, technology-centered lifestyles makes a dramatic reversal of this trend challenging, if not unrealistic, for many families.
The Cincinnati Children’s and UAB research opens a promising new avenue: redesigning indoor lighting. The concept is to engineer artificial light sources that more closely reproduce the beneficial wavelengths present in natural sunlight, particularly the indigo spectrum. This passive intervention could offer a scalable and less burdensome solution than current active management strategies.
In a pioneering move in 2021, building upon earlier research into the profound effects of light on eye development, Cincinnati Children’s became the first pediatric hospital to install a programmable, full-spectrum lighting system in its neonatal intensive care unit (NICU). Researchers are actively studying the long-term effects of this innovative system on infant development and health outcomes. While specialty lamps are already available for other biological purposes, such as light therapy for seasonal affective disorder or to help regulate circadian rhythms for jet lag, lighting products specifically designed with the precise indigo characteristics to prevent myopia are not yet widely available to the public.
Translating Laboratory Success to Clinical Reality
The next crucial step involves rigorous human trials. The Science of Light Center at Cincinnati Children’s is at the forefront of investigating how diverse lighting environments can influence children’s health. While the tree shrew experiments yielded compelling results, validating whether indigo-enriched lighting can effectively prevent myopia in children remains paramount.
The upcoming phase of this transformative research is anticipated to involve installing these improved lighting systems in participating daycare centers. Children attending these facilities would then be longitudinally followed, allowing researchers to compare their rates of myopia development with those observed in daycare centers utilizing conventional lighting. This large-scale, real-world study will be instrumental in confirming the translational potential of their laboratory findings.
According to Dr. Lang, the overarching objective is not simply to increase the brightness of indoor spaces. Instead, the focus is on making artificial light more "biologically complete" by meticulously tuning its spectrum to emulate the natural light under which human eyes evolved. "What’s our best option? It is to change the lighting environment inside," Lang states with conviction. "If future clinical studies confirm the findings, indigo-enriched lighting could become a safe, passive, and scalable way to help reduce childhood myopia risk." This vision points towards a future where our indoor environments actively promote ocular health, rather than inadvertently contributing to a growing public health crisis.
A Collaborative Endeavor and Future Horizons
This groundbreaking research is a testament to the power of interdisciplinary collaboration. It was conducted through a close partnership between Richard Lang’s team at Cincinnati Children’s and Rafael Grytz’s group at UAB. Significant contributions also came from Takahiro Yamashita at Kyoto University and Mehlika Inanici at The University of Washington, underscoring the international scope of this scientific endeavor.
The project received substantial financial backing from a diverse array of organizations, reflecting the broad interest and recognition of its importance. Key funding sources included multiple grants from the National Eye Institute of the National Institutes of Health (EY026588, EY036560, EY032633, EY003039, EY038143, EY028666, EY032029, EY032752, EY032566, and EY034456), along with support from the National Institute of General Medical Science (GM152641). International funding was provided by the Japan Agency for Medical Research and Development (22gm1510007). Additional crucial support came from philanthropic organizations such as the EyeSight Foundation of Alabama, Research to Prevent Blindness, the Henry M. Hollis Fund, the Emma and Irving Goldman Scholar Endowed Chair, and the Cincinnati Children’s Hospital Research Foundation.
Looking to the future, both Grytz and Lang have reported that they are named as inventors on pending patents covering lighting devices directly related to this research. Furthermore, Grytz is the founder and Chief Scientific Officer (CSO) of Electric Indigo, a UAB startup company in which UAB holds an ownership interest. These developments signal a clear intent to translate this pivotal scientific discovery into practical, commercially viable solutions that could benefit millions worldwide. The prospect of a future where simply changing the light bulbs in our homes and schools could safeguard children’s vision represents a profound and exciting paradigm shift in the global fight against myopia.
